NBA Marijuana Policy: Players Restricted from Promoting Cannabis Brands, But THC Drug Testing Removed in New Agreement
In a surprising turn of events, the National Basketball Association (NBA) has unveiled its latest collective bargaining agreement, revealing that players will not be allowed to promote marijuana companies, despite early reports suggesting otherwise. However, there is a significant change regarding THC drug testing. The league has decided to remove drug testing requirements for THC, while permitting players to passively invest in the cannabis industry.
Contrary to initial speculations, the newly released summary document outlines that while players are permitted to promote companies that produce CBD-infused products, they will continue to be prohibited from endorsing marijuana companies directly. This means that fans shouldn’t expect to see popular players like Kevin Durant launching their own line of cannabis products anytime soon or publicly supporting marijuana brands.
Nevertheless, other previously reported details have been confirmed by the “Key Deal Points” memo summarizing the collective bargaining agreement, which is still being finalized. The document was first reported by SFGATE. Effective July 1, the new CBA allows players to invest in CBD companies without specific restrictions and grants them the opportunity to hold a passive, non-controlling interest in marijuana product manufacturers.
Perhaps the most significant change in the league’s policy is the removal of marijuana drug testing requirements. According to the deal points paper, “Marijuana will be removed from the Prohibited Substances List.” However, it should be noted that if a team has reason to suspect a player is under the influence of marijuana during NBA or team-related activities or has a dependency issue, the player may be referred to a treatment program.
While players are now free to legally consume cannabis off the court, they are still prohibited from using marijuana during games or other team-related events, such as press conferences. The document clarifies that “The NBA and teams may impose reasonable discipline on players who are under the influence while engaged in any team activity or in violation of the law.”
This reform essentially formalizes the league’s temporary suspension of cannabis testing for the past three seasons. Prominent marijuana advocate and NBA commentator, Snoop Dogg, commended the policy change, applauding the league’s efforts to allow players to use cannabis for medicinal purposes, potentially as an alternative to opioids.
Michele Roberts, a former head of the National Basketball Players Association (NBPA) and board member of major cannabis company Cresco Labs, had previously predicted that a formal policy change would be forthcoming. Notably, in 2021, NBA star Kevin Durant partnered with the online marijuana marketplace Weedmaps for a multi-year collaboration aimed at destigmatizing cannabis and showcasing its potential benefits for athlete wellness and recovery.
As more states continue to legalize cannabis, an increasing number of professional sports leagues have taken steps to reform their marijuana policies. Recently, Nevada sports regulators voted in favor of a proposed amendment to protect athletes from penalties for using or possessing marijuana in compliance with state law. Additionally, the Chicago Cubs became the first Major League Baseball (MLB) team to partner with a CBD company, following the league’s previous league-wide partnership with a popular CBD brand.
Among professional sports leagues, MLB has been more responsive to the changing marijuana landscape. In 2020, it clarified that players would not face punishment for cannabis use outside of working hours, but personal sponsorship by a marijuana company or investments in the industry were prohibited. UFC also announced in 2021 that it would no longer penalize fighters for positive marijuana tests. Furthermore, the NCAA recommended new rules last year, allowing student athletes to retain eligibility even after a positive marijuana test.
The NFL’s drug testing policy underwent significant changes in 2020 as part of a collective bargaining agreement. With the latest developments in the NBA’s marijuana policy, it is evident that professional sports leagues are adapting to the evolving landscape and embracing more lenient approaches.
In conclusion, the NBA’s new collective bargaining agreement restricts players from promoting marijuana companies but removes THC drug testing requirements. While players can invest in CBD companies without restrictions and hold a passive interest in marijuana product manufacturers, the league maintains strict rules regarding marijuana use during team activities. This policy change reflects a broader trend in professional sports leagues as they navigate the shifting attitudes and legalities surrounding cannabis.
